How to legally get Wegovy online in Texas

In recent years, GLP-1 medications like Wegovy, Ozempic, and Mounjaro have revolutionized weight management treatment. With high demand and busy schedules, many people wonder: can you legally get these medications through telehealth? The short answer is yes—in most states, you can obtain GLP-1 weight loss medications via telehealth consultations without an in-person visit. However, state-specific regulations create important variations that patients should understand.

Understanding GLP-1 Medications and Telehealth Prescribing

GLP-1 receptor agonists were initially developed for type 2 diabetes but have gained FDA approval for weight management due to their effectiveness in reducing appetite and slowing digestion. Unlike older weight loss drugs that were classified as controlled substances, GLP-1 medications are not controlled substances, which significantly impacts how they can be prescribed via telehealth.

Key Federal Regulations for Telehealth Prescribing

Under federal law, non-controlled medications like GLP-1s can be prescribed through telehealth without requiring an in-person examination. The Ryan Haight Act’s in-person requirement only applies to controlled substances (like certain anxiety or ADHD medications), not to medications like Wegovy or Ozempic.

While special DEA pandemic flexibilities for controlled substances are currently extended through December 31, 2025, these extensions don’t directly affect GLP-1 medications, which have always been eligible for telehealth prescribing under federal law.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Rules for GLP-1 Medications

Though federal law permits telehealth prescribing of GLP-1s, state regulations vary considerably:

States with No In-Person Requirements

These states allow telehealth prescribing of GLP-1s without requiring any in-person visits:

• California: Fully permits telehealth prescribing with no in-person requirement
• Connecticut: Allows virtual consultations for GLP-1s but requires behavioral counseling
• Florida: Permits telehealth prescribing but requires BMI ≥30 and follow-ups at least every 3 months
• Illinois: Has a permanent telehealth law with no in-person requirements
• New York: Permits telehealth prescribing with no in-person mandate
• Pennsylvania: Allows telehealth prescribing without in-person requirements
• Washington: Pioneer telehealth state with no special restrictions for GLP-1s

States Requiring Initial In-Person Visits

These states generally require an initial in-person examination before allowing telehealth prescribing of weight management medications:

• Arkansas: Has some of the strictest telemedicine rules, requiring an initial in-person exam
• Delaware: Requires an initial physical examination before telehealth weight management treatment
• Georgia: Mandates in-person exam prior to telehealth prescribing of weight loss medications
• Mississippi: State law requires seeing the patient in-person once before telehealth weight management
• North Dakota: Expects an initial hands-on evaluation for weight loss treatment
• South Carolina: Requires an initial in-person examination and periodic evaluations
• Texas: Generally expects an initial in-person exam prior to telehealth prescribing
• Utah: Recommends initial in-person evaluation for obesity treatment
• Virginia: Requires initial physical exam, lab work, and personalized diet/exercise plan

Qualifying for GLP-1 Medications via Telehealth

Regardless of state, legitimate telehealth providers will require:

• Medical screening: Detailed health history and current medications
• BMI documentation: Typically requiring BMI ≥30, or ≥27 with weight-related conditions
• Previous weight management efforts: History of trying diet and exercise
• Lab work: Some providers require recent labs or will order them
• Contraindication screening: Checking for conditions that would make GLP-1s unsafe

At Klarity Health, our providers conduct thorough evaluations to ensure GLP-1 medications are appropriate, safe, and likely to benefit you. We follow all state-specific regulations while making the process as convenient as possible.

The Telehealth Consultation Process

When seeking GLP-1 medications through telehealth, expect:

1. Pre-visit questionnaire: Detailed medical history, weight goals, and previous treatments
2. Video consultation: A face-to-face virtual visit with a licensed provider
3. Prescription decision: Based on your medical appropriateness and state regulations
4. Regular follow-ups: Typically every 1-3 months to monitor progress and adjust treatment

Provider Qualifications: Who Can Prescribe GLP-1s?

The type of healthcare provider allowed to prescribe GLP-1 medications varies by state:

• Physicians (MDs/DOs): Can prescribe in all states via telehealth (if licensed in patient’s state)
• Nurse Practitioners: Have full independent prescribing authority in states like Washington, California, and New York; require physician collaboration in states like Texas, Florida, and Pennsylvania
• Physician Assistants: Generally can prescribe under physician supervision, with varying levels of autonomy by state

Avoiding Red Flags in Telehealth Weight Loss Treatment

Be wary of telehealth services that:

• Promise guaranteed prescriptions without thorough evaluation
• Offer ‘compounded’ versions of GLP-1s (the FDA banned routine compounding of semaglutide in 2025)
• Don’t schedule follow-ups or monitor your progress
• Lack transparency about provider credentials or licensing
• Skip discussions about risks, benefits, and alternative treatments

Insurance Coverage and Costs

Insurance coverage for GLP-1 weight loss medications varies widely:

• Many insurance plans cover GLP-1s for diabetes but require prior authorization for weight management
• Medicare typically doesn’t cover GLP-1s specifically for weight loss
• Some commercial plans are expanding coverage as evidence of long-term health benefits grows

Klarity Health works with patients to determine insurance coverage options while also offering transparent cash pricing for those without coverage.

Conclusion: Telehealth Access to GLP-1 Medications

Telehealth has made GLP-1 weight management medications more accessible to millions of Americans who might otherwise face barriers to treatment. While state regulations create some variations in how these medications can be prescribed, most states now permit telehealth prescribing with appropriate medical oversight.

The landscape continues to evolve as more states embrace telehealth and update their regulations. For the most current information about GLP-1 prescribing in your state, consulting with a knowledgeable telehealth provider like Klarity Health can help navigate the regulations while ensuring you receive appropriate, effective care.

Ready to explore whether GLP-1 medications might be right for your weight management journey? Klarity Health offers convenient telehealth consultations with experienced providers who understand both the clinical aspects of GLP-1 therapy and the regulatory requirements in your state.

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025 (www.axios.com) (www.dea.gov). Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)
Sources newer than 2024: 15 of 18 sources (most sources are 2024–2025; older sources used only for baseline context)

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid